Evidence map›Paper›PMID 31876492›Full record

ArticleThe Lancet. Infectious diseases2020

Tuberculosis test results using fresh versus biobanked urine samples with FujiLAM.

Tobias Broger, Monde Muyoyeta, Andrew D Kerkhoff, Claudia M Denkinger, Emmanuel Moreau

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Accuracy of a Novel Urine Test, Fujifilm SILVAMP Tuberculosis Lipoarabinomannan, for the Diagnosis of Pulmonary Tuberculosis in Children.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  17. Article
  18. Getting to the point in point-of-care diagnostics for tuberculosis.The Journal of clinical investigation · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Tobias BrogerFIND, 1202 Geneva, Switzerland.
Monde MuyoyetaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Andrew D KerkhoffDivision of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, Department of Medicine, University of California, San Francisco, CA, USA.
Claudia M DenkingerFIND, 1202 Geneva, Switzerland; Division of Tropical Medicine, Center of Infectious Diseases, University of Heidelberg, Heidelberg, Germany.
Emmanuel MoreauFIND, 1202 Geneva, Switzerland. Electronic address: emmanuel.moreau@finddx.org.

Funding

Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
NIAID NIH HHS T32 AI060530
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Point-of-Care SystemsTuberculosisHumansLipopolysaccharideslipoarabinomannanLipopolysaccharides

Identifiers

PMID31876492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.